Clinical trials
Hypercalcemia clinical trials
Below are recruiting hypercalcemia clinical trials, each written for real people, not researchers. We’re tracking 7 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03301038RecruitingPhase 2
Rifampin for a rare calcium disorder caused by CYP24A1
This trial tests rifampin to improve high blood and/or urine calcium that happens in people with CYP24A1 gene changes. It also checks safety by watching liver and kidney blood tests and pregnancy status.
Philadelphia, PennsylvaniaAges 6 months–65 years - NCT04265599Recruiting
Study of high calcium after oil injections
This study looks at why some people develop high blood calcium after receiving an oil injection into a muscle. It may help researchers understand the cause and find better ways to treat it.
CopenhagenAges 18 years+ - NCT04292288Recruiting
Study of high calcium after paraffin oil injection
This trial looks at people who previously received a paraffin oil injection and may have related health effects, such as high calcium levels. It aims to better understand what happens after this type of injection and what care may be needed.
HerlevAges 18–80 - NCT04987073Recruiting
Vitamin D type added for CYP24A1 vitamin D deficiency
This study tests a vitamin D-like medicine for people with a specific genetic cause of low active vitamin D (CYP24A1 deficiency). If you have the right gene change, it may help your body use vitamin D more normally.
Caen, NormandyAges 18 years+ - NCT03935984RecruitingPhase 4
Calcitonin before scan to improve parathyroid detection
This study looks at whether taking calcitonin before a special parathyroid scan (SPECT-CT) makes the scan easier to read. It’s for people with primary hyperparathyroidism who want surgery, and may help doctors find the right gland more reliably.
Toledo, OhioAges 18 years+ - NCT05585593Recruiting
Registry for long-term low parathyroid hormone conditions
This study keeps an ongoing registry (a secured collection of patient information) for people with long-term low parathyroid hormone problems or similar conditions. It may help researchers better understand these conditions and improve future care.
Würzburg, BavariaAges 18 years+ - NCT06763549Enrolling by invitation
AI-powered wearable patch for heart and lung monitoring
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
Melbourne, FloridaAges 18 years+
Hear when a new Hypercalcemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hypercalcemia?
- Yes. Clin2 currently lists 7 recruiting hypercalcemia studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hypercalcemia trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hypercalcemia trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.